Unity Biotechnology Investor Relations Material
Latest events
Ophthalmology Day 2024
Unity Biotechnology
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Unity Biotechnology Inc
Access all reports
Unity Biotechnology, Inc., a biotechnology company, focuses on developing therapeutics designed to slow, halt, or reverse diseases associated with aging. The company's research primarily targets cellular senescence and age-related biology, with an emphasis on ophthalmologic and neurologic diseases. Unity Biotechnology's product pipeline includes UBX1325, currently in clinical trials for treating age-related eye diseases such as diabetic macular edema and age-related macular degeneration. It is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Unity Biotechnology Inc
Ophthalmology Day 2024
Unity Biotechnology Inc
Ophthalmology Day 2024
Unity Biotechnology Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
UBX
Country
🇺🇸 United States